Cedars Sinai Intellectual Property Co - 05 Apr 2022 Form 4 Insider Report for Prometheus Biosciences, Inc.

Role
10%+ Owner
Signature
Timothy K. Andrews, attorney-in-fact
Issuer symbol
N/A
Transactions as of
05 Apr 2022
Net transactions value
$0
Form type
4
Filing time
05 Apr 2022, 17:49:33 UTC
Previous filing
25 Jun 2021
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXDX Common Stock Other $0 -142,376 -2.8% $0.000000 4,866,132 05 Apr 2022 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the transfer of an aggregate total of 142,376 shares of the Issuer's common stock held by Cedars Sinai Intellectual Property Company (CSIPC) to three inventors of Cedars-Sinai Medical Center (CSMC) as compensation for their services.
F2 The securities reported herein are held directly by CSIPC, a wholly owned subsidiary of CSMC.